에 대한 최신 뉴스 Kura Oncology (NASDAQ:KURA) 주식

Kura Oncology

Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.

Baidu Photo by testing on Shutterstock

Earnings

Equities

News

Eurozone

Commodities

Markets

Trading Ideas

BIDU

CLCO

KURA

PYXS

QUBT

SNOW

미국 주식은 목요 상승세를 보였으며, 다우존스 지수가  460포인트 이상 상승 마감했다. 다우는 1.06% 상승한 43,870.35로 마감되었고, 나스닥은 0.033% 상승한 18,972.42로 마쳤다. S&amp;P 500 지수도 0.53% 상승한 5,948.71로 마감되었다.

다우존스는 1% 상승 및 나스닥이 소폭 상승: 3분기 실적 발표 후 바이두 주가 하락

Kura Oncology Inc

Kura Sushi Inc

Kura Sushi USA, Inc. - Class A Common Stock

Kura Sushi USA Inc

Kuraray Co Ltd

The Future Fund Managing Partner, Gary Black, cautioned investors on Tuesday against Tesla Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) robotaxi valuations that project share prices of $2,000 or higher, arguing that such forecasts ignore market realities and competition.
What Happened: Black criticized supply-based approaches that assume Tesla will capture nearly all ride-hailing business from Uber Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) and Lyft Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>), noting that even if Tesla captured the entire profits of Uber and Lyft combined, the impact on its earnings would be minimal—adding $1.50 per share to Tesla's Earnings Per Share.
&#8220;Tesla doesn&#8217;t have a first-mover advantage, has no ride-hailing marketing, and hasn&#8217;t been approved for a single autonomous deployment license in any state yet,&#8221; Black wrote on X, adding that both Uber and Lyft will likely offer fully autonomous rides concurrently with Tesla.
Black&#8217;s skepticism extends to Tesla&#8217;s <a href="https://www.benzinga.com/markets/25/04/44979720/teslas-robotaxi-launch-in-june-will-likely-be-a-non-event-says-gary-black-this-isnt-really-a-test-market-its-an-experiment">upcoming Austin robotaxi launch</a>, which he recently described as an &#8220;experiment&#8221; rather than a true market test, with only 10-20 vehicles initially deployed.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">I keep seeing <a href="https://twitter.com/search?q=%24TSLA&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$TSLA</a> price targets that incorporate Robotaxi valuations of $2,000/share, $3,000/share or more. Most erroneously assume TSLA somehow takes 99% of the ride-hailing business away from UBER and LYFT once TSLA is approved for unsupervised autonomy and is awarded…
&mdash; Gary Black (@garyblack00) <a href="https://twitter.com/garyblack00/status/1917345526837830080?ref_src=twsrc%5Etfw">April 29, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/markets/equities/25/04/45090925/trumps-call-to-jeff-bezos-over-amazons-tariff-display-plans-draws-criticism-from-peter-schiff-this-is-the-type-of-stuff-you-might-expect-to-see-in-china">Trump&#8217;s Call To Jeff Bezos Over Amazon&#8217;s Tariff Display Earns Peter Schiff&#8217;s Ire: &#8216;Type Of Stuff You Might Expect To See In China&#8217;</a>
Why It Matters: Black&#8217;s concerns contrast sharply with ARK Invest CEO Cathie Wood&#8216;s bullish $2,600 price target, which values <a href="https://www.benzinga.com/news/25/03/44345980/cathie-wood-stands-by-teslas-2600-price-target-despite-40-stock-drop-its-winner-take-most">Tesla at over $9 trillion by 2029</a>. Wood views robotaxis as an &#8220;$8 trillion to $10 trillion opportunity&#8221; that could transform Tesla from a manufacturer to a software company with margins approaching 90%.
Despite recent positive movement after Tesla&#8217;s quarterly earnings call, where CEO Elon Musk announced he would &#8220;significantly&#8221; reduce his time at the Department of Government Efficiency, Black maintains that regulatory realities will prevent Tesla from dominating the <a href="https://www.benzinga.com/25/04/44945402/wedbushs-dan-ives-raises-teslas-price-target-to-350-as-musk-promises-to-significantly-reduce-doge-time">autonomous ride-hailing market.</a>
&#8220;Despite Tesla&#8217;s fleet, data, and compute advantages,&#8221; Black wrote, &#8220;regulators will ensure that others are approved soon after. And Tesla&#8217;s lack of marketing skills remains its Achilles heel.&#8221;
Benzinga Edge&#8217;s Stock Rankings indicate that while Tesla faces a short- to long-term negative price trend, it still outperforms Lucid Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCID#NASDAQ">LCID</a>), Rivian Automotive Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>), and Nio Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>) in terms of momentum. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Sign up for more insights</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/media/25/04/45089307/trump-says-hes-already-ended-inflation-at-michigan-rally-held-to-mark-100-days-in-office-promises-to-protect-medicare-and-social-security-democrats-plan-senate-ba" target="_blank" rel="noreferrer noopener">Trump Says He's ‘Already Ended Inflation' At Michigan Rally Held To Mark 100 Days In Office, Promises To Protect Medicare And Social Security — Democrats Plan Senate Barrage</a></li>
</ul>
Photo Courtesy: Ian Dewar Photography On Shutterstock.com
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

LCID

LYFT

RIVN

TSLA

UBER

Tesla's 'Marketing Skills Remain Its Achilles Heel,' Says Gary Black As Robotaxi Valuations Ignore Market Limits—Full Uber, Lyft Profits Still Fall Short Of $2,000 Target

Economist Justin Wolfers pushed back against President Donald Trump&#8217;s inconsistent recent remarks on trade deals, taxes, and tariff revenue, calling his position "fundamentally incoherent."
What Happened: On Tuesday, the Australian economist dismissed Trump's claim that tariff revenue could be used to reduce or eliminate income taxes. Speaking on Yahoo Finance's The Morning Brief, Wolfers was blunt: &#8220;The president is lying, it's that simple,&#8221; he said, adding that there is &#8220;no bill, process, or proposal to Congress&#8221; backing such a plan.
What&#8217;s more concerning than the claim itself is the "fundamental incoherence" of Trump's position, arguing that tariff revenue could replace income taxes, while simultaneously pushing for trade deals that would reduce those very tariffs, Wolfers says.
See More: <a href="https://www.benzinga.com/media/25/04/45089307/trump-says-hes-already-ended-inflation-at-michigan-rally-held-to-mark-100-days-in-office-promises-to-protect-medicare-and-social-security-democrats-plan-senate-ba">Trump Says He&#8217;s &#8216;Already Ended Inflation&#8217; At Michigan Rally Held To Mark 100 Days In Office, Promises To Protect Medicare And Social Security — Democrats Plan Senate Barrage</a>
&#8220;The president's got a choice,&#8221; Wolfers says. He can either strike trade deals that open global markets to American businesses and give U.S. consumers access to international goods, or &#8220;stick with very high tariffs and get some revenue out of it — you cannot have both.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The President has a choice: Deals, or tariff revenue. You can have one, but you can&#39;t have both. <a href="https://t.co/eZuMBurvmt">pic.twitter.com/eZuMBurvmt</a>
&mdash; Justin Wolfers (@JustinWolfers) <a href="https://twitter.com/JustinWolfers/status/1917195865602593178?ref_src=twsrc%5Etfw">April 29, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
&#8220;That's the whole problem with this tariff policy, what the president wants has changed day to day,&#8221; Wolfers says. He noted that the rationale behind it all has shifted repeatedly, from national security and reshoring manufacturing to raising revenue and cutting the trade deficit.
This uncertainty, Wolfers says, is making it difficult for businesses to plan ahead, much like America's foreign trade partners, who need clarity on whether and how to engage in negotiations with the U.S.
Why It Matters: Wolfers has been a <a href="https://benzinga.com/markets/equities/25/04/44620423/trumps-sweeping-tariffs-could-cost-us-20-trillion-crash-markets-warn-economists-monstrously-destructive">vocal critic of Trump&#8217;s tariffs</a> and chaotic economic policies since the very beginning, posting just a day after &#8220;Liberation Day&#8221; that the tariffs would be &#8220;monstrously destructive,&#8221; and would ultimately hurt &#8220;working Americans more than anyone else.&#8221;
Several other leading experts have been <a href="https://benzinga.com/markets/25/04/44944580/trump-says-tariffs-could-replace-income-tax-experts-warn-the-math-doesnt-work">skeptical of Trump&#8217;s proposal</a> to replace income tax with tariffs over the past week. Mark Zandi, the chief economist at Moody&#8217;s stated that the IRS has already collected $1.14 trillion in income taxes this year, and that &#8220;If you get to $100 billion to $200 billion [in tariff revenue], you&#8217;ll be pretty lucky.&#8221;
The administration's &#8220;shock and awe&#8221; tariff strategy has <a href="https://www.benzinga.com/25/04/44680956/billionaire-banker-backs-trumps-shock-and-awe-tariff-policies-slams-bill-ackmans-call-for-90-day-pause">drawn some support</a>, including from Andrew Beal, founder of Beal Financial Corporation, who argued that the tariffs are necessary to promote fair trade and redefine America's role in the global economy.
Photo Courtesy: Evan El-Amin On Shutterstock.com
Read More: <a href="https://www.benzinga.com/markets/equities/25/04/45090925/trumps-call-to-jeff-bezos-over-amazons-tariff-display-plans-draws-criticism-from-peter-schiff-this-is-the-type-of-stuff-you-might-expect-to-see-in-china">Trump&#8217;s Call To Jeff Bezos Over Amazon&#8217;s Tariff Display Earns Peter Schiff&#8217;s Ire: &#8216;Type Of Stuff You Might Expect To See In China&#8217;</a>

Government

Trump Can Either Have His Cake Or Eat It, Economist Justin Wolfers Calls Out President's 'Fundamental Incoherence' On Trade Deals And Tariffs

• Net revenues of €35.8 billion, down 14% compared to Q1 2024 primarily due to lower shipment volumes, as well as unfavorable mix and pricing&nbsp;
• Consolidated shipments(1) of 1,217 thousand units, down 9%, reflect lower North American production, a consequence of extended holiday downtime in January, product transition impacts and lower industry LCV volumes in Enlarged Europe • The Company is suspending its 2025 financial guidance due to tariff-related uncertainties&nbsp;
• The Company is highly engaged with policymakers on tariff policies, while taking action to reduce impacts

STLA

Stellantis Q1 Revenue Falls 14% to €35.8B; Shipments Down 9% to 1.22M Units on North America Downtime And EU LCV Weakness; Suspends 2025 Guidance Due To Tariff-Related Uncertainties

Macro Economic Events

Econ #s

Economics

Germany Retail Sales (MoM) For March -0.2% Vs. -0.4% Est.; 0.2% (Revised) Prior

U.K. Nationwide HPI (MoM) For April -0.6% Vs. -0.1% Est.; 0.0% Prior

U.K. Nationwide HPI (YoY) For April 3.4% Vs. 4.1% Est.; 3.9% Prior

HEC Montréal's ERPsim Lab Secures $2M For AI-Powered Data Visualization Project With SAP Canada And Partner Universities

<ul>
<li>Early market traction underscores strong market demand and momentum, confirms long-term strategy ahead of the first official FX product launch this June, securing recognition from an East Coast business validates FF's unique "Three Pillars" model of user acquisition, co-creation, and user operations.</li>
</ul>

Faraday Future Intelligent Electric Inc. - Class A Common Stock

FFAI

Faraday Future's "Three Pillars" Strategy Pays Off With First FX Super One Deal, Reinforcing Global EV Ambitions

ADXN

Addex Expands Dipraglurant Strategy With Exclusive IP Access From Sinntaxis Targeting Brain Injury Functional Recovery

France Gross Domestic Product (QoQ) Preliminary For Q1 0.1% Vs. 0.1% Est.; -0.1% Prior

France Gross Domestic Product (YoY) Preliminary For Q1 0.8% Vs. 0.7% Est.; 0.8% (Revised) Prior

France Consumer Spending (MoM) For March -1.0% Vs. 0.0% Est.; -0.2% (Revised) Prior

Reported Earlier, China Caixin Manufacturing Purchasing Managers Index For April 50.4 Vs. 49.7 Est.; 51.2 Prior

Reported Earlier, China Non-Manufacturing Purchasing Managers Index For April 50.4 Vs. 50.6 Est.; 50.8 Prior

Reported Earlier, China Manufacturing Purchasing Managers Index For April 49.0 Vs. 49.7 Est.; 50.5 Prior

Reported Earlier, China Composite Purchasing Managers' Index For April 50.2 Vs. 51.4 Prior

Reported Earlier, Australia Trimmed Mean Consumer Price Index (QoQ) For Q1 0.7% Vs. 0.6% Est.; 0.5% Prior

Reported Earlier, Australia Consumer Price Index (QoQ) For Q1 0.9% Vs. 0.8% Est.; 0.2% Prior

Reported Earlier, Australia Consumer Price Index (YoY) For Q1 2.4% Vs. 2.3% Est.; 2.4% Prior

BBJP

WisdomTree Trust Japan Total Dividend Fund

Reported Earlier, Japan Industrial Production (MoM) Preliminary For March -1.1% Vs. -0.5% Est.; 2.3% Prior

Press Releases

Kura Oncology to Report Fourth Quarter and Full Year 2024 Financial Results

Kura Oncology to Participate in Three Upcoming Investor Conferences

Kura Oncology Reports Fourth Quarter and Full Year 2024 Financial Results

Financing

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Kura Oncology Announces Preclinical Data for KO-2806 Selected for Oral Presentation at the 2025 AACR Annual Meeting

Kura Oncology to Participate in Stifel Targeted Oncology Forum

Management

Health Care

Kura Oncology and Kyowa Kirin Announce Submission of New Drug Application for Ziftomenib to FDA

Kura Oncology to Report First Quarter 2025 Financial Results

General

Kura Oncology Announces First Patients Dosed in Phase 1 Combination Trial of Ziftomenib for the Treatment of Advanced GIST

Absci

Abivax

Bicycle Therapeutics plc - American Depositary Shares

Bicycle Therapeutics

Capricor Therapeutics, Inc. - Common Stock

Capricor Therapeutics

Celcuity

Cullinan Therapeutics, Inc. - Common Stock

Cullinan Therapeutics

Cogent Biosciences

Immatics

Keros Therapeutics

MeiraGTx Hldgs

Mereo BioPharma Group plc - American Depositary Shares

Mereo BioPharma Group

Organogenesis Holdings

Precigen

Prothena Corporation plc - Ordinary Shares

Prothena Corp

Regenxbio

Relay Therapeutics

Sage Therapeutics

Sionna Therapeutics

Stoke Therapeutics

Savara

Tourmaline Bio

Tyra Biosciences

Upstream Bio

Valneva

Verve Therapeutics

JMP Securities

HC Wainwright & Co.

Wedbush

Scotiabank

미국 주식은 목요 상승세를 보였으며, 다우존스 지수가  460포인트 이상 상승 마감했다.
다우는 1.06% 상승한 43,870.35로 마감되었고, 나스닥은 0.033% 상승한 18,972.42로 마쳤다. S&amp;P 500 지수도 0.53% 상승한 5,948.71로 마감되었다.
참고: <a href="https://www.benzinga.com/24/11/42086207/jim-cramer-likes-devon-energy-but-says-this-energy-stock-is-far-superior-to-devon">짐 크레이머가 데본 에너지를 좋아하지만, 다른 주식이 &#8216;훨씬 우수하다&#8217;고 언급</a>
주요 상승 및 하락 부문
목요일에 에너지 주식이 1.46% 상승했다.
통신 서비스 주식은 목요일에 1.39% 하락했다.
주요 뉴스
바이두(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>)의 주식은 회사가 3분기 실적을 발표한 후 5.90% 하락 마감했다. 이 회사는 분기 매출이 47억 8천만 달러로 전년 대비 3% 감소했지만, 애널리스트 컨센서스 예상치인 46억 9천만 달러는 상회했다. 또한, 조정된 주당 순이익이 2.37달러로 애널리스트 컨센서스 예상치인 2.35달러를 상회했다.
상승 주식
<ul>
<li>퀀텀 컴퓨팅(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>)의 주식은 광자 칩 파운드리 추가 주문을 받았다고 발표한 후 29.35% 상승하여 4.76달러로 마감되었다.</li>
<li>스노우플레이크(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>)의 주식은 3분기 실적이 예상보다 좋게 나타난 후 32.71% 상승하여 171.35달러로 마감되었다. 스노우플레이크는 4분기 제품 매출이 9억 6천만 달러에서 9억 1천 1백만 달러 사이로 예상되며, 전년 대비 약 23% 증가할 것으로 보인다. 또한, 연간 제품 매출 전망을 33억 5천 6백만 달러에서 34억 3천만 달러로 상향 조정하여 전년 대비 29% 증가를 나타냈다.</li>
<li>유니버설 테크니컬 인스티튜트(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UTI#NYSE">UTI</a>)의 주식은 분기 실적이 긍정적으로 나타난 후 18.70% 상승하여 23.61달러로 마감되었다.</li>
</ul>
하락 주식
<ul>
<li>쿨 컴퍼니(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLCO#NYSE">CLCO</a>)의 주식은 3분기 실적 발표 후 13.31% 하락하여 9.22달러로 마감되었다.</li>
<li>픽시스 온콜로지(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYXS#NASDAQ">PYXS</a>)의 주식은 PYX-201 임상 1상 데이터 발표 후 45.03% 하락하여 2.10달러로 마감되었다.</li>
<li>쿠라 온콜로지(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KURA#NASDAQ">KURA</a>)의 주식은 글로벌 전략적 협력을 발표한 후 36.77% 하락하여 10.06달러로 마감되었다.</li>
</ul>
원자재
원자재 뉴스에 따르면, 유가는 1.7% 상승하여 배럴당 70.06달러로 거래되었고, 금은 0.8% 상승하여 온스당 2,673.60달러로 거래되었다.
목요일에 은은 0.3% 하락하여 온스당 30.920달러로 거래되었고, 구리는 0.9% 하락하여 파운드당 4.1170달러로 거래되었다.
유로존
유럽 주식은 오늘 상승 마감했다. 유로존의 STOXX 600 지수는 0.41% 상승, 독일의 DAX는 0.74% 상승, 프랑스의 CAC 40은 0.21% 상승했다. 스페인의 IBEX 35 지수는 0.19% 상승했으며, 런던의 FTSE 100 지수는 0.79% 상승했다.
유로존의 소비자 신뢰지수는 11월에 -13.7로 1.2포인트 하락했다.
아시아 태평양 시장
아시아 시장은 목요일에 대부분 하락했다. 일본의 닛케이 225가 0.85% 하락하고, 홍콩의 항셍지수는 0.53% 하락했다. 중국 상하이 종합지수는 0.07% 상승했으며, 인도의 BSE 센섹스는 0.54% 하락했다.
경제 지표
<ul>
<li>미국의 기존 주택 판매는 10월에 전월 대비 3.5% 증가하여 연율 약 396만 채로 집계되었다.</li>
<li>필라델피아 연방은행 제조업지수는 11월에 -5.5로 하락하여 10.3에서 감소했으며, 시장 예상치인 8과 비교되었다.</li>
<li>미국의 초기 실업수당 청구 건수는 11월 16일 주에 6,000건 감소하여 213,000건으로 집계되었다.</li>
</ul>
이제 이걸 읽어보세요:
<ul>
<li><a href="https://www.benzinga.com/24/11/42112636/top-3-tech-stocks-which-could-rescue-your-portfolio-in-q4">4분기에 포트폴리오를 구할 수 있는 3대 기술주</a></li>
</ul>
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요. 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Kura Oncology

뉴스

에 대한 최신 뉴스 Kura Oncology (NASDAQ:KURA) 주식

목요일, 11월 21, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌